Novo Nordisk Pharmatech
Novo Nordisk Pharmatech A/S is a global and leading manufacturer of pharmaceutical ingredients for the pharmaceutical and biopharmaceutical industries. The company specialises in cGMP manufactured Recombinant Insulin, enzymes, resins, and quaternary ammonium compounds (Quats).
The mission is to enable better medicines by providing sustainable pharmaceutical materials through innovative and customised solutions.
Novo Nordisk Pharmatech helps the world´s largest pharmaceutical and biopharmaceutical industries reduce their risk for raw materials by using pharma-grade products with a high level of consistency, purity, quality, and reliability.
The high purity, non-therapeutic Insulin is sourced directly from parent company Novo Nordisk. Recombinant Insulin is a key component in serum-free growth media for mammalian cells used to manufacture monoclonal antibodies, virus vaccines, gene therapy products, and other biological drug products approved by regulatory bodies worldwide, including FDA and EMA.
More than 70 years of experience has provided the know-how to ensure maximum product purity and keep impurities to even lower levels than pharmacopeial standards.